The Legacy Of Angels is located in Waseca, MN. The organization was established in 2009. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Legacy Of Angels is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Legacy Of Angels generated $2.3m in total revenue. The organization has seen a slow decline revenue. Over the past 8 years, revenues have fallen by an average of (2.7%) each year. All expenses for the organization totaled $2.5m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (5.0%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Legacy Of Angels has awarded 110 individual grants totaling $19,842,350. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Paul Rosenau President | 5 | $0 | |
Gillian Hauboldt Treasurer | 2 | $0 | |
Mariah Stone Mary Kay Delvo Secretary | 2 | $0 | |
Heather Techmeier Director | 40 | $127,500 | |
Dr Gabriel Cohn Director | 40 | $175,000 | |
Julie Mccarrier Director | 2 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $11,000 |
Interest on Savings | $1,836 |
Dividends & Interest | $848,561 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $1,331,521 |
Capital Gain Net Income | $1,331,521 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $123,878 |
Total Revenue | $2,316,796 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $302,500 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $88,408 |
Interest | $0 |
Taxes | $32,179 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $10,528 |
Printing and publications | $0 |
Other expenses | $389,250 |
Total operating and administrative expenses | $1,226,562 |
Contributions, gifts, grants paid | $1,266,475 |
Total expenses and disbursements | $2,493,037 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $484 |
Savings and temporary cash investments | $215,910 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $7,523 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $2,255,922 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $30,291,573 |
Accounts payable and accrued expenses | $759 |
Grants payable | $1,339,690 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $1,340,449 |
Over the last fiscal year, The Legacy Of Angels has awarded $2,606,165 in support to 20 organizations.
Grant Recipient | Amount |
---|---|
UNIVERSITY OF ILLINOIS PURPOSE: IMMUNE RESPONSES IN PERIPHERAL NERVES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTS FOR KD | $125,000 |
UNIVERSITY OF ILLINOIS PURPOSE: CHALLENGING THE CAPACITY OF AAV-GALC GENE THERAPY TO COPE WITH MODIFIERS OF ADULT BRAIN FUNCTION | $85,000 |
UNIVERSITY OF BUFFALO PURPOSE: INNOVATIVE MODEL SYSTEMS TO STUDY & BOOST INNATE IMMUNITY IN KD | $205,983 |
BIOMEDICAL RESEARCH INSTITUTE OF NJ PURPOSE: PSYCHOSINE PROFILING AND EVALUATION AS A THERAPEUTIC FOR KD | $129,834 |
UNIVERSITY OF CONNECTICUT HEALTH CE PURPOSE: EVALUATION OF IMMUNOMODULATORY THERAPY FOR THE TREATMENT OF KD | $17,950 |
KRABBECONNECT PURPOSE: PARENT-REPORTED DISEASE BURDEN IN INFANTILE & LATE INFANTILE KD | $122,708 |